Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV9-mediated gene therapy for treating mucopolysaccharidosis type I

AAV9-mediated gene therapy for treating mucopolysaccharidosis type I

US Patent 11890329 · Granted Feb 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy for ceroid lipofuscinoses2025
Gene therapy for ceroid lipofuscinoses2025
Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidat2025
Recombinant adeno-associated virus for treatment of GRN-associated adult-onset n2025
Recombinant adeno-associated virus for treatment of GRN-associated adult-onset n2025
Gene therapy for treating citrullenemia2025
Compositions useful in treatment of metachromatic leukodystrophy2025
GLP-1 and use thereof in compositions for treating metabolic diseases2025
GLP-1 and use thereof in compositions for treating metabolic diseases2025
Composition for treatment of Crigler-Najjar syndrome2024
Methods and compositions for treating metastatic breast cancer and other cancers2024
Methods and compositions for treating metastatic breast cancer and other cancers2024